Is primary biliary cirrhosis an autoimmune disease?

Area of Science:

• Immunology
• Hepatology
• Autoimmunity

Background:

• Primary biliary cirrhosis (PBC) is a chronic liver disease with an unknown etiology.
• Evidence suggests an autoimmune basis, involving immune responses against mitochondrial autoantigens.

Purpose of the Study:

• To review the experimental and clinical evidence supporting an autoimmune origin of PBC.
• To discuss the role of anti-mitochondrial antibodies (AMAs) in PBC pathogenesis.

Main Methods:

• Review of existing literature on PBC, focusing on immunological findings.
• Analysis of experimental data and clinical observations related to autoimmune markers in PBC.

Main Results:

• Demonstration of antibodies and T cell clones targeting mitochondrial autoantigens in PBC patients.
• Lymphocytic infiltration and destruction of small bile ducts observed in PBC.
• Anti-mitochondrial antibodies (M2 type) are diagnostic and target the E2 subunit of pyruvate dehydrogenase complex (PDC-E2).

Conclusions:

• While direct proof is absent, substantial evidence points to an autoimmune mechanism in PBC.
• The pathogenic role of AMAs is still under investigation, with potential triggers including molecular mimicry or aberrant autoepitope expression.